PortfoliosLab logoPortfoliosLab logo
FIGR vs. UTHR
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

FIGR vs. UTHR - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Figure Technology Solutions, Inc (FIGR) and United Therapeutics Corporation (UTHR). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, FIGR achieves a -31.49% return, which is significantly lower than UTHR's 11.71% return.


FIGR

1D
-3.82%
1M
-17.58%
YTD
-31.49%
6M
-37.36%
1Y
3Y*
5Y*
10Y*

UTHR

1D
1.12%
1M
-4.24%
YTD
11.71%
6M
6.64%
1Y
90.07%
3Y*
34.77%
5Y*
25.37%
10Y*
18.22%
*Multi-year figures are annualized to reflect compound growth (CAGR)

FIGR vs. UTHR - Yearly Performance Comparison


2026 (YTD)2025
FIGR
Figure Technology Solutions, Inc
-31.49%13.44%
UTHR
United Therapeutics Corporation
11.71%22.89%

Correlation

The correlation between FIGR and UTHR is 0.04, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.


Correlation
Correlation (All Time)
Calculated using the full available price history since Sep 11, 2025

0.04

Fundamentals

Market Cap

FIGR:

$6.96B

UTHR:

$25.69B

EPS

FIGR:

$0.79

UTHR:

$27.00

PE Ratio

FIGR:

35.47

UTHR:

20.16

PEG Ratio

FIGR:

0.03

UTHR:

0.66

PS Ratio

FIGR:

10.30

UTHR:

8.19

PB Ratio

FIGR:

5.39

UTHR:

4.35

Total Revenue (TTM)

FIGR:

$618.46M

UTHR:

$3.17B

Gross Profit (TTM)

FIGR:

$392.90M

UTHR:

$2.74B

EBITDA (TTM)

FIGR:

$212.61M

UTHR:

$1.75B

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

FIGR vs. UTHR — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

FIGR

Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.


UTHR
UTHR Risk / Return Rank: 9494
Overall Rank
UTHR Sharpe Ratio Rank: 8787
Sharpe Ratio Rank
UTHR Sortino Ratio Rank: 9696
Sortino Ratio Rank
UTHR Omega Ratio Rank: 9393
Omega Ratio Rank
UTHR Calmar Ratio Rank: 9797
Calmar Ratio Rank
UTHR Martin Ratio Rank: 9696
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

FIGR vs. UTHR - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Figure Technology Solutions, Inc (FIGR) and United Therapeutics Corporation (UTHR). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


FIGRUTHRDifference
Sharpe ratioReturn per unit of total volatility

Sortino ratioReturn per unit of downside risk

Omega ratioGain probability vs. loss probability

1.49

Calmar ratioReturn relative to maximum drawdown

8.51

Martin ratioReturn relative to average drawdown

19.15

FIGR vs. UTHR - Sharpe Ratio Comparison


Loading charts...

Drawdowns

FIGR vs. UTHR - Drawdown Comparison

The maximum FIGR drawdown since its inception was -65.80%, smaller than the maximum UTHR drawdown of -93.18%. Use the drawdown chart below to compare losses from any high point for FIGR and UTHR.


Loading charts...

Drawdown Indicators


FIGRUTHRDifference

Max Drawdown

Largest peak-to-trough decline

-65.80%

-93.18%

+27.38%

Max Drawdown (1Y)

Largest decline over 1 year

-10.64%

Max Drawdown (3Y)

Largest decline over 3 years

-33.00%

Max Drawdown (5Y)

Largest decline over 5 years

-33.00%

Max Drawdown (10Y)

Largest decline over 10 years

-55.56%

Current Drawdown

Current decline from peak

-62.14%

-8.79%

-53.35%

Average Drawdown

Average peak-to-trough decline

-34.07%

-35.28%

+1.21%

Ulcer Index

Depth and duration of drawdowns from previous peaks

4.72%

Volatility

FIGR vs. UTHR - Volatility Comparison


Loading charts...

Volatility by Period


FIGRUTHRDifference

Volatility (1M)

Calculated over the trailing 1-month period

5.81%

Volatility (6M)

Calculated over the trailing 6-month period

25.97%

Volatility (1Y)

Calculated over the trailing 1-year period

103.00%

47.47%

+55.53%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

103.00%

35.06%

+67.94%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

103.00%

35.02%

+67.98%

Dividends

FIGR vs. UTHR - Dividend Comparison

Neither FIGR nor UTHR has paid dividends to shareholders.


Tickers have no history of dividend payments

Financials

FIGR vs. UTHR - Financials Comparison

This section allows you to compare key financial metrics between Figure Technology Solutions, Inc and United Therapeutics Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.00200.00M400.00M600.00M800.00MJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025AprilJulyOctober2026
167.01M
781.50M
(FIGR) Total Revenue
(UTHR) Total Revenue
Values in USD except per share items

FIGR vs. UTHR - Profitability Comparison

The chart below illustrates the profitability comparison between Figure Technology Solutions, Inc and United Therapeutics Corporation over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

0.0%20.0%40.0%60.0%80.0%100.0%JulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025AprilJulyOctober20260
82.9%
Portfolio components
FIGR - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Figure Technology Solutions, Inc reported a gross profit of 0.00 and revenue of 167.01M. Therefore, the gross margin over that period was 0.0%.

UTHR - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, United Therapeutics Corporation reported a gross profit of 648.10M and revenue of 781.50M. Therefore, the gross margin over that period was 82.9%.

FIGR - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Figure Technology Solutions, Inc reported an operating income of 41.94M and revenue of 167.01M, resulting in an operating margin of 25.1%.

UTHR - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, United Therapeutics Corporation reported an operating income of 325.80M and revenue of 781.50M, resulting in an operating margin of 41.7%.

FIGR - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Figure Technology Solutions, Inc reported a net income of 44.95M and revenue of 167.01M, resulting in a net margin of 26.9%.

UTHR - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, United Therapeutics Corporation reported a net income of 274.90M and revenue of 781.50M, resulting in a net margin of 35.2%.


Frequently Asked Questions


FIGR and UTHR have a correlation of 0.04, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Portfolio Optimizer

Find the right allocation for FIGR and UTHR

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer